NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP is investigating Advaxis, Inc. (“Advaxis” or the “Company”) (NASDAQ:ADXS) in connection with possible violations of federal securities laws by the Board of Directors of the Company.
To get more information, click here: http://zlk.9nl.com/advaxis-adxs. There is no cost or obligation to you.
On January 21, 2015, SeekingAlpha published an article alleging that in a recent presentation Advaxis misrepresented the tumor response data for its ADXS-HPV compound, overstating its effectiveness in shrinking tumors. The article further alleges that the Company has misled investors regarding the design of its planned Phase 3 trial.
If you own common stock in Advaxis and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/advaxis-adxs.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.